Indication:Granulocytopenia resulting from chemotherapy For cancer patients taking bone marrow suppression drugs, especially after the treatment with some strong bone marrow deprivation chemical drugs, the in

Specification:75ug, 150ug,300ug

Dosage Form:Injection

Active Ingredients:Recombinant human granulocyte colony-stimulating factor

Route of Administration:Subcutaneous Injection

Shelf Life:2 years

Storage:2℃-8℃

Package:1 vial/ syringe

Place of Origin:China

Qualification:Chinese GMP

Indication:Cancer patients receiving myelosuppressive chemotherapy or bone marrow transplant to decrease the incidence of infection and patients with neutropenia.

Specification:300mcg/vial, 150mcg/vial, 75mcg/vial

Dosage Form:Injection

Active Ingredients:rhG-CSF

Route of Administration:Subcutaneous Injection

Shelf Life:3 years

Storage:2℃-8℃

Package:5vials/box

Place of Origin:china

Qualification:Chinese GMP

Indication:PegLeukim is indicated to decrease the incidence of infection as manifested by neutropenia in patients with malignancies receiving myelosuppression anti-cancer drugs associated with a significant inci

Specification:3mg/vial

Dosage Form:Injection

Active Ingredients:peg-rhG-CSF

Route of Administration:Subcutaneous Injection

Shelf Life:3 years

Storage:2℃-8℃

Package:1vial/box

Place of Origin:China

Qualification:Chinese GMP

Indication:1. Cancer chemotherapy and other reasons lead to neutropenia. 2. To promote the increase in the number of neutrophils af

Specification:75g/0.3ml/branch, 100g/0.4ml/branch, 125g/0.5ml/branch, 150g/0.6ml/branch, 200g/0.8ml/branch, 300g/1.2ml/branch

Dosage Form:Injection

Active Ingredients:recombinant human granulocyte colony-stimulating factor

Route of Administration:Subcutaneous Injection

Shelf Life:3 years

Storage:2℃-8℃

Package:10 branch/box

Place of Origin:China

Qualification:Chinese GMP

Chemical Formula:C8H11ClN2O

Molecular Weight:186

Assay:98%NLT

Chemical Formula:C8H11ClN2O

Molecular Weight:186

Assay:98%NLT